ProfileGDS4718 / 218426_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 61% 66% 67% 63% 63% 70% 74% 60% 65% 64% 65% 62% 73% 73% 73% 67% 65% 70% 69% 71% 61% 64% 64% 61% 61% 66% 56% 67% 60% 73% 72% 72% 67% 63% 66% 70% 71% 64% 65% 74% 65% 69% 68% 72% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.2119761
GSM549102patient 115, normal, homogenized [OPG study]6.5612766
GSM549104patient 119, normal, homogenized [OPG study]6.6671567
GSM549108patient 138, normal, homogenized [OPG study]6.329463
GSM549119patient 077, normal, homogenized [OPG study]6.3249163
GSM549133patient 032, cancer, homogenized [OPG study]6.9116970
GSM549139patient 042, cancer, homogenized [OPG study]7.2254874
GSM549099patient 107, normal, homogenized [OPG study]6.1047260
GSM549109patient 139, normal, homogenized [OPG study]6.4868965
GSM549110patient 046, normal, homogenized [OPG study]6.380864
GSM549114patient 063, normal, homogenized [OPG study]6.4653865
GSM549122patient 082, normal, homogenized [OPG study]6.2930162
GSM549134patient 033, cancer, homogenized [OPG study]7.1798373
GSM549136patient 036, cancer, homogenized [OPG study]7.1949473
GSM549140patient 044, cancer, homogenized [OPG study]7.1642773
GSM549111patient 047, normal, homogenized [OPG study]6.6960767
GSM549113patient 057, normal, homogenized [OPG study]6.4431465
GSM549132patient 031, cancer, homogenized [OPG study]6.8569270
GSM549137patient 038, cancer, homogenized [OPG study]6.856269
GSM549142patient 047, cancer, homogenized [OPG study]6.8867171
GSM549100patient 110, normal, homogenized [OPG study]6.1824361
GSM549107patient 135, normal, homogenized [OPG study]6.382364
GSM549115patient 068, normal, homogenized [OPG study]6.4152764
GSM549116patient 072, normal, homogenized [OPG study]6.1630461
GSM549120patient 078, normal, homogenized [OPG study]6.1730961
GSM549131patient 030, cancer, homogenized [OPG study]6.5782266
GSM549118patient 074, normal, homogenized [OPG study]5.882956
GSM549129patient 027, cancer, homogenized [OPG study]6.6969567
GSM549123patient 088, normal, homogenized [OPG study]6.1242360
GSM549124patient 006, cancer, homogenized [OPG study]7.0676473
GSM549126patient 015, cancer, homogenized [OPG study]7.068472
GSM549128patient 025, cancer, homogenized [OPG study]7.167872
GSM549103patient 117, normal, homogenized [OPG study]6.5900567
GSM549117patient 073, normal, homogenized [OPG study]6.281663
GSM549138patient 041, cancer, homogenized [OPG study]6.6033366
GSM549141patient 045, cancer, homogenized [OPG study]6.9296670
GSM549130patient 028, cancer, homogenized [OPG study]6.9484771
GSM549101patient 111, normal, homogenized [OPG study]6.451964
GSM549105patient 128, normal, homogenized [OPG study]6.4723565
GSM549106patient 134, normal, homogenized [OPG study]7.3180774
GSM549112patient 048, normal, homogenized [OPG study]6.5069365
GSM549125patient 011, cancer, homogenized [OPG study]6.7755569
GSM549127patient 024, cancer, homogenized [OPG study]6.8349268
GSM549135patient 035, cancer, homogenized [OPG study]7.1340472